Browse by Countries

Request/Offer Detail

Title: Anti-GD2 Immunocytokine, IgG (hu14.18)-IL2
TypeName: Business Offer
Request Date:2017/07/31
Country: Afghanistan
Summary: This antibody-cytokine fusion protein was achieved by conjugating/fusing the Anti-GD2 IgG to IL2. It was expressed in CHO and purified with affinity chromatography. The fusion protein retains its ability to activate IL2 responsive cells through the IL2 receptor and retains its ability to bind to GD2-positive tumor cells and to deliver IL2 to their surface. This immunocytokine was designed for treating neuroblastomas, medulloblastomas, astrocytomas, melanomas, small-cell lung cancer, osteosarcomas and other soft tissue sarcomas.
Description: This antibody-cytokine fusion protein was achieved by conjugating/fusing the Anti-GD2 IgG to IL2. It was expressed in CHO and purified with affinity chromatography. The fusion protein retains its ability to activate IL2 responsive cells through the IL2 receptor and retains its ability to bind to GD2-positive tumor cells and to deliver IL2 to their surface. This immunocytokine was designed for treating neuroblastomas, medulloblastomas, astrocytomas, melanomas, small-cell lung cancer, osteosarcomas and other soft tissue sarcomas.. http://www.creativebiolabs.net/Anti-GD2-Immunocytokine-IgG-hu14-18-IL2-22495.htm
Advantages:
Comments:
RequestId: 382
Name:Creative Biolabs
Telphone:
Email:marketing@creative-biolabs.com

Sponsors

smartportal sponsors